Literature DB >> 11012104

Latinas, amniocentesis and the discourse of choice.

C H Browner1, H M Preloran.   

Abstract

Little attention has been paid to the impact of the increasingly routine use of fetal diagnosis on how U.S. minority women experience their pregnancies and decide whether to have their fetuses tested. Using narrative analysis, we offer the account of one Latina who, despite considerable turmoil, ultimately accepted an offer of amniocentesis. We describe her reasoning in choosing a course of action. Data from interviews with 147 Latinas who were faced with the same decision are used to contextualize the case study material. We seek to illuminate how a blending of Mexican and European American cultural influences helped shape the woman's experience and define the dilemma she faced when she learned her fetus might be born with a grave or incurable condition because she was ideologically opposed to abortion.

Entities:  

Mesh:

Year:  2000        PMID: 11012104     DOI: 10.1023/a:1005671703311

Source DB:  PubMed          Journal:  Cult Med Psychiatry        ISSN: 0165-005X


  27 in total

1.  What do sequential behavioral patterns suggest about the medical decision-making process?: modeling home case management of acute illnesses in a rural Cameroonian village.

Authors:  G W Ryan
Journal:  Soc Sci Med       Date:  1998-01       Impact factor: 4.634

2.  Transplacental needle passage and other risk-factors associated with second trimester amniocentesis.

Authors:  T Marthin; S Liedgren; M Hammar
Journal:  Acta Obstet Gynecol Scand       Date:  1997-09       Impact factor: 3.636

3.  The psychological impact of false positive elevations of maternal serum alpha-fetoprotein.

Authors:  B K Burton; R G Dillard; E N Clark
Journal:  Am J Obstet Gynecol       Date:  1985-01-01       Impact factor: 8.661

4.  Women's decision-making in prenatal screening.

Authors:  P Santalahti; E Hemminki; A M Latikka; M Ryynänen
Journal:  Soc Sci Med       Date:  1998-04       Impact factor: 4.634

5.  Oncology and narrative time.

Authors:  M J Del Vecchio Good; T Munakata; Y Kobayashi; C Mattingly; B J Good
Journal:  Soc Sci Med       Date:  1994-03       Impact factor: 4.634

6.  The logic of well being. Therapeutic narratives in Cairo, Egypt.

Authors:  E A Early
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

7.  'Because of the risks': how US pregnant women account for refusing prenatal screening.

Authors:  S Markens; C H Browner; N Press
Journal:  Soc Sci Med       Date:  1999-08       Impact factor: 4.634

8.  Access to reproductive genetic services for low-income women and women of color.

Authors:  Laurie Nsiah-Jefferson
Journal:  Fetal Diagn Ther       Date:  1993-04       Impact factor: 2.587

9.  Characteristics of women who refuse an offer of prenatal diagnosis: data from the California maternal serum alpha fetoprotein blood test experience.

Authors:  N Press; C H Browner
Journal:  Am J Med Genet       Date:  1998-08-06

10.  Providers and consumers of prenatal genetic testing services: what do the national data tell us?

Authors:  F J Meaney; S M Riggle; G C Cunningham
Journal:  Fetal Diagn Ther       Date:  1993-04       Impact factor: 2.587

View more
  3 in total

1.  Strategies for motivating Latino couples' participation in qualitative health research and their effects on sample construction.

Authors:  H M Preloran; C H Browner; E Lieber
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

2.  Fatalism or destiny? A qualitative study and interpretative framework on Dominican women's breast cancer beliefs.

Authors:  Karen R Flórez; Alejandra N Aguirre; Anahí Viladrich; Amarilis Céspedes; Ana Alicia De La Cruz; Ana F Abraído-Lanza
Journal:  J Immigr Minor Health       Date:  2008-02-06

3.  Concurrent use of cultural health practices and Western medicine during pregnancy: exploring the Mexican experience in the United States.

Authors:  Deborah I Barragan; Kelly E Ormond; Michelle N Strecker; Jon Weil
Journal:  J Genet Couns       Date:  2011-07-16       Impact factor: 2.537

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.